基于FCM/FACS-GC/UPLC-MS/MS联用解析特定肠道菌预防结直肠癌作用及机制
结题报告
批准号:
81973096
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
李磊
依托单位:
学科分类:
卫生分析化学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
李磊
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
结直肠癌(CRC)是常见消化道恶性肿瘤,尚无可靠防控方法。研究表明,CRC患者脂质代谢异常,肠道菌群紊乱;特定肠道益生菌Akkermansia muciniphila(Akk)及外膜蛋白影响机体脂质代谢及恶性肿瘤免疫疗效。课题组预实验发现,Akk菌/外膜蛋白能改变巨噬细胞表型,抑制CRC形成,但机制不清。因此猜想:Akk/外膜蛋白可通过扰动脂质代谢影响M2巨噬细胞极化及功能,并反向调控肠道菌群和免疫代谢,抑制CRC发生发展。本研究结合荧光标记单抗流式细胞术(FCM)及荧光激活细胞分选与气相/超高效液相色谱-高分辨串联质谱(FACS-GC/UPLC-MS/MS)联用构建Akk菌高效检测和巨噬细胞分选-代谢组学新方法;探明Akk菌/外膜蛋白干预免疫细胞亚群及脂质代谢效应和CRC模型动物肠道菌群及免疫代谢变化,并开展临床样本验证。该研究从卫生分析化学角度为CRC免疫代谢防控提供新原理和新技术。
英文摘要
Colorectal cancer (CRC) is a common malignant tumour in digestive tract, and there is no reliable method for its prevention and control. Studies have shown that there are abnormal lipid metabolism and disordered intestinal flora in CRC patients, and a pecific intestinal bacteria probiotic Akkermansia muciniphila (Akk) and its outer membrane protein may affect lipid metabolism and immunotherapy response of malignant tumors. The results of our preliminary experiment have shown that Akk bacteria/outer membrane protein can change macrophage phenotype and inhibit CRC formation, but the mechanism is unclear. Therefore, it is speculated that Akk bacteria/outer membrane protein can affect M2 macrophages polarization and function by disturbing its lipid metabolism, and reverse regulate intestinal flora and immune metabolism to inhibit the development of CRC. In this study, a new method for efficient detection of Akk bacteria and analysis of macrophage metabolism was established by combining fluorescent labeled monoclonal antibody flow cytometry (FCM) and fluorescent activated cell sorting (FACS) with gas chromatography/ultra-high performance liquid chromatography- high resolution tandem mass spectrometry (GC/UPLC-MS/MS). The CRC mouse model induced by azoxymethane (AOM)/dextran sodium sulfate (DSS) is employed to explore the effects of Akk bacteria/outer membrane protein on immune cell subsets and its lipid metabolism by FACS-GC/UPLC-MS/MS excepting gut microbiota based 16S rRNA. People with colorectal cancer will be recruited in affiliated hospital under the guidance of ethical permission and informed consent, and the clinic samples of blood, feces and tumor tissue is used to detect simultaneously as in animal model specimens. Finally, validation and correlation detection are carried out based on univariate and multivariate analysis. This study provides new principles and techniques for the prevention and control of immune metabolism of malignant tumor CRC from the perspective of hygienic analytical chemistry.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.cej.2021.129773
发表时间:2021-04-20
期刊:CHEMICAL ENGINEERING JOURNAL
影响因子:15.1
作者:Dai, Jiayong;Chen, Jiaxin;Hu, Zhijun
通讯作者:Hu, Zhijun
DOI:10.1128/aac.00151-22
发表时间:2022-06-21
期刊:Antimicrobial agents and chemotherapy
影响因子:4.9
作者:
通讯作者:
DOI:10.1039/d1fo02172a
发表时间:2021-09-01
期刊:FOOD & FUNCTION
影响因子:6.1
作者:Gu, Zhenyang;Pei, Wenlong;Zhang, Zhan
通讯作者:Zhang, Zhan
DOI:10.3389/fmicb.2020.563139
发表时间:2020
期刊:Frontiers in microbiology
影响因子:5.2
作者:Chen M;Zhong G;Wang S;Zhu J;Tang L;Li L
通讯作者:Li L
DOI:--
发表时间:2021
期刊:Chinese Medical Journal
影响因子:--
作者:Zhenyang Gu;Wenlong Pei;Yi Zhang;Jun Zhu;Lei Li;Zhan Zhang
通讯作者:Zhan Zhang
微纳米形貌重金属对慢性炎症影响的多组学分析及机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    李磊
  • 依托单位:
金属化学形态纳米识别- FI-HPLC/GC-ICP-MS联用分析及代谢组学研究
  • 批准号:
    81673228
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2016
  • 负责人:
    李磊
  • 依托单位:
混合型高分辨质谱联用解析CADs代谢谱及对恶性肿瘤协同干预作用机制
  • 批准号:
    81473020
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2014
  • 负责人:
    李磊
  • 依托单位:
植物化学物联合调控氧化应激损伤指纹图谱与时效性研究
  • 批准号:
    81072338
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    李磊
  • 依托单位:
国内基金
海外基金